-
-
-
-
-
-
-
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements
-
-
-
-
-
-
-
XOMA to acquire Generation Bio for $4.29 per share plus contingent payments
-
-
-
-
-
-
-
Irish court approves XOMA Royalty's acquisition of Mural Oncology
-
-
-
-
-
-
-
Mural Oncology shareholders approve XOMA Royalty acquisition
-
-
-
-
-
-
-
XOMA, Ltd. (XOMA) PT Raised to $50 at Benchmark
-
-
-
-
-
-
-
XOMA Royalty to acquire LAVA Therapeutics for up to $1.24 per share
-
-
-
-
-
-
-
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
-
1,160,149 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

